21.06

2.14% -0.46

Stevanato Group Spa (STVN)

Overview News Price History Option Chain Why STVN Down? Discussions Forecast Dividend History

Stevanato Group Spa stock is traded at $21.06, with a volume of 445.36K. It is down -2.14% in the last 24 hours and up +6.26% over the past month. Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.

Previous Close:

$21.52

Open:

$21.46

24h Volume:

445.36K

Relative Volume:

1.21

Market Cap:

$5.75B

Revenue:

$1.40B

Net Income/Loss:

$164.00M

P/E Ratio:

35.05

EPS:

0.6009

Net Cash Flow:

$-11.09M

1W Performance:

+3.90%

1M Performance:

+6.26%

6M Performance:

+31.54%

1Y Performance:

-5.01%

1-Day Range:

$20.97

$21.55

1-Week Range:

$19.99

$21.61

52-Week Range:

$12.89

$28.00

Stevanato Group Spa Stock (STVN) Company Profile

Name

Stevanato Group Spa

Sector

Healthcare (1080)

Industry

Medical Instruments & Supplies (56)

Phone

Address

Employee

5,795

Twitter

Next Earnings Date

2026-08-04

Latest SEC Filings

STVN's Discussions on Twitter

Compare STVN vs ISRG, BDX, ALC, RMD, MDLN

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
STVN Stevanato Group Spa	21.06	5.80B	1.40B	164.00M	-11.09M	0.6009
ISRG Intuitive Surgical Inc	394.51	141.76B	11.03B	3.16B	3.22B	8.7251
BDX Becton Dickinson Co	183.40	50.00B	21.37B	1.41B	3.07B	3.9437
ALC Alcon Inc	74.25	35.57B	10.63B	819.00M	1.59B	1.6577
RMD Resmed Inc	224.46	32.78B	5.54B	1.52B	1.74B	10.37
MDLN Medline Inc	35.74	31.15B	29.14B	1.07B	1.05B	1.1956

Stevanato Group Spa Stock (STVN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-02-25	Resumed	Morgan Stanley	Equal-Weight
Dec-13-24	Initiated	Wolfe Research	Outperform
Dec-03-24	Resumed	Morgan Stanley	Equal-Weight
Apr-22-24	Initiated	Exane BNP Paribas	Outperform
Nov-01-23	Downgrade	Jefferies	Buy → Hold
Sep-26-23	Initiated	Stephens	Overweight
Sep-19-23	Initiated	CJS Securities	Market Outperform
Aug-24-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Aug-10-21	Initiated	BofA Securities	Buy
Aug-10-21	Initiated	Citigroup	Buy
Aug-10-21	Initiated	Jefferies	Buy
Aug-10-21	Initiated	KeyBanc Capital Markets	Overweight
Aug-10-21	Initiated	Morgan Stanley	Overweight
Aug-10-21	Initiated	Wells Fargo	Overweight

View All

Stevanato Group Spa Stock (STVN) Latest News

Aug 14, 2026

T. Rowe Price (STVN) cuts Stevanato stake to 3,921 shares, 0.0% - Stock Titan

Aug 14, 2026

Aug 13, 2026

Artisan Partners (STVN) discloses 2.6M Stevanato shares held for clients - Stock Titan

Aug 13, 2026